Detection of Glioma‐Derived Exosomes with the Biotinylated Antibody‐Functionalized Titanium Nitride Plasmonic Biosensor
Source abstract
Abstract
Abstract Titanium nitride (TiN), as an excellent alternative plasmonic supporting material compared to gold and silver, exhibits tunable plasmonic properties in the visible and near‐infrared spectra. However, label‐free surface plasmon resonance biosensing with TiN is seldom reported due to lack of proper surface functionalization protocols. Herein, this study reports biotinylated antibody‐functionalized TiN (BAF‐TiN) for high‐performance label‐free biosensing applications. The BAF‐TiN biosensor can quantitatively detect exosomes of 30–200 nm extracellular vesicles, isolated from a human glioma cell line. The limit of detection for an exosomal membrane protein with the BAF‐TiN biosensor is found to be 4.29 × 10−3µg mL−1 for CD63, an exosome marker, and 2.75 × 10−3µg mL−1 for epidermal growth factor receptor variant‐III, a glioma specific mutant protein, respectively. In conclusion, combining the biocompatibility, high stability, and excellent label‐free sensing performance of TiN, the BAF‐TiN biosensor could have great potential for the detection of cancer biomarkers, including exosomal surface proteins.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials Science and Engineering City University of Hong Kong 83 Tat Chee Avenue Kowloon Hong Kong SAR 999077 China
Department of Civil Environmental and Geomatic Engineering Institute of Environmental Engineering ETH Zürich Zürich 8093 Switzerland
Department of Biomedical Sciences City University of Hong Kong 83 Tat Chee Avenue Kowloon Hong Kong SAR 999077 China
References (34)
Show source-provided references
1. 10.1364/OME.2.00047810.1364/OME.2.000478 ↗
2. 10.1016/j.msea.2006.09.02110.1016/j.msea.2006.09.021 ↗
3. 10.1021/acsphotonics.7b0012710.1021/acsphotonics.7b00127 ↗
4. 10.1111/jace.1219710.1111/jace.12197 ↗
5. 10.1088/0957-4484/21/11/11520110.1088/0957-4484/21/11/115201 ↗
6. 10.1016/j.bios.2018.02.00610.1016/j.bios.2018.02.006 ↗
7. 10.1021/nl403345710.1021/nl4033457 ↗
8. Chirumamilla M. · Adv. Opt. Mater. · 2017 · 5 · 1151
9. 10.1016/j.tsf.2013.01.02410.1016/j.tsf.2013.01.024 ↗
10. 10.1016/j.tsf.2006.09.05110.1016/j.tsf.2006.09.051 ↗
11. Hove R. P. · Biomed Res. Int. · 2015 · 2015 · 485975
12. 10.1016/S0142-9612(01)00185-510.1016/S0142-9612(01)00185-5 ↗
13. 10.1021/cr068107d10.1021/cr068107d ↗
14. 10.1021/acsami.7b1506610.1021/acsami.7b15066 ↗
15. Thakur A. · Proceedings of American Association for Cancer Research Anual Meeting 2018 · 2018 · 3720
16. 10.3892/or.2017.574210.3892/or.2017.5742 ↗
17. 10.18632/oncotarget.1363510.18632/oncotarget.13635 ↗
18. 10.1038/nri85510.1038/nri855 ↗
19. 10.1016/j.ceb.2009.03.00710.1016/j.ceb.2009.03.007 ↗
20. 10.1039/C5AN01610J10.1039/C5AN01610J ↗
21. 10.1111/j.1750-3639.2009.00318.x10.1111/j.1750-3639.2009.00318.x ↗
22. 10.1016/j.bios.2017.03.03610.1016/j.bios.2017.03.036 ↗
23. 10.21037/jlpm.2017.12.0810.21037/jlpm.2017.12.08 ↗
24. 10.1039/C5RA07875J10.1039/C5RA07875J ↗
25. 10.1116/1.486208410.1116/1.4862084 ↗
26. 10.1016/j.ymeth.2015.04.00810.1016/j.ymeth.2015.04.008 ↗
27. 10.1038/nmat216210.1038/nmat2162 ↗
28. 10.1021/cr200117810.1021/cr2001178 ↗
29. 10.1038/nchem.135210.1038/nchem.1352 ↗
30. 10.1038/ncb180010.1038/ncb1800 ↗
31. 10.1074/mcp.RA118.00064410.1074/mcp.RA118.000644 ↗
32. 10.1002/adom.20160071710.1002/adom.201600717 ↗
33. 10.1016/j.sna.2017.12.06610.1016/j.sna.2017.12.066 ↗
34. 10.1016/j.matlet.2018.01.06810.1016/j.matlet.2018.01.068 ↗